H-Glu-OtBu · HCl

H-Glu-OtBu · HCl is a protected L-glutamic acid derivative presented as the tert-butyl ester hydrochloride salt, where the side-chain carboxylic acid remains functionalizable while the α-carboxyl group is masked as an OtBu ester. The molecule contains an α-amino group protected as the N-terminal acetylated form (H-Glu indicates a free amino functionality under the specified nomenclature) and a chiral center at the glutamate α-position, enabling stereochemically defined peptide coupling. The OtBu ester and the salt form (· HCl) shape its acid-base behavior, improving handling while remaining compatible with standard peptide synthesis deprotection strategies. The glutamate side-chain carboxyl group provides a reactive handle for selective amidation, esterification, or orthogonal protection, making the compound a practical chiral amino acid building block and downstream intermediate for amino acid derivatization and peptide analog construction.

1. Peptide Synthesis

H-Glu-OtBu · HCl supports peptide building block preparation in peptide coupling workflows where glutamate residues must be incorporated with controlled protection of the α-carboxyl group. The tert-butyl ester (OtBu) functions as a removable C-terminal protection element, while the glutamate side-chain carboxyl group can be selectively protected or activated to achieve chemoselective bond formation. The hydrochloride salt form helps maintain amino functionality for coupling chemistry and can be managed in standard peptide assembly sequences that rely on orthogonal deprotection. Downstream, the resulting glutamyl-containing peptides and peptide fragments can be used to generate sequence-defined libraries for biochemical research and structure-activity relationship studies, with stereochemistry preserved at the glutamate center.

2. Side-Chain Functionalization

H-Glu-OtBu · HCl enables side-chain functionalization strategies that exploit the glutamate γ-carboxyl group as a programmable chemical handle. The protected α-carboxyl as an OtBu ester allows derivatization of the side-chain carboxyl without premature loss of the C-terminal protecting group, supporting selective formation of amides, mixed anhydrides, or activated esters for subsequent conjugation steps. The chiral glutamate backbone can then be carried into functionalized amino acid derivatives, including carboxylate-bearing peptidomimetics and chemically modified peptide fragments used in chemical biology. The product's salt and ester protection pattern make it suitable for iterative synthetic sequences that require controlled deprotection and re-protection to tune reactivity and solubility.

3. Protected Amino Acid Chemistry

H-Glu-OtBu · HCl serves as a chiral protected amino acid intermediate for orthogonal protection design in amino acid derivatization and protected amino acid synthesis. The OtBu ester provides a protection element for the α-carboxyl that can be removed under conditions compatible with many peptide synthesis protecting-group schemes, while the glutamate side-chain carboxyl can be managed through additional protection or direct activation depending on the target. The defined stereochemistry at the α-carbon supports reproducible incorporation into larger constructs, including peptide building blocks and amino acid-based fragments for synthetic organic chemistry. The hydrochloride salt form also supports practical handling during intermediate preparation, enabling downstream transformations that generate C-terminally functionalized glutamate derivatives and process-ready intermediates for fine chemical synthesis.

4. Bioconjugation Chemistry

H-Glu-OtBu · HCl can be applied to bioconjugation workflows where glutamate-derived linkers or peptide handles are required for attaching biomolecules through carboxyl-reactive chemistry. The glutamate γ-carboxyl group provides a functional group platform for forming amide or ester linkages to biomolecule scaffolds, while the OtBu ester can be used to control which carboxyl group participates during sequential conjugation steps. The chiral amino acid framework supports incorporation into peptide-based linkers that maintain defined geometry and spacing in conjugates used for biochemical assays and molecular recognition studies. Downstream utility includes preparation of glutamate-containing conjugation intermediates that can be further converted into labeled probes, affinity reagents, or assay components for applied chemical biology and analytical research.

5. Pharmaceutical Intermediate Preparation

H-Glu-OtBu · HCl is suitable for pharmaceutical intermediate preparation where protected glutamate motifs are incorporated into larger synthetic sequences for drug discovery chemistry and process development. The protected amino acid structure, with an ester-masked α-carboxyl and a side-chain carboxyl suitable for controlled activation, supports modular assembly of glutamyl fragments that can later be converted into acids, amides, or other functionalized carboxyl derivatives. The stereogenic glutamate center provides a defined chiral element that is often required for consistent structure-activity relationship exploration and for generating stereochemically uniform intermediates. The compound's protection strategy aligns with industrially relevant synthetic planning, enabling manufacturing routes that separate protection, coupling, and deprotection steps to manage reactivity and isolate intermediates for specialty chemical production.

1. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

2. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

3. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics